BioSyent, Inc. (RX.V)
15.70
+0.20
(+1.29%)
CAD |
TSXV |
Aug 25, 16:00
BioSyent Debt to Equity Ratio : 0.0685 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0685 |
| March 31, 2026 | 0.1166 |
| December 31, 2025 | 0.0203 |
| September 30, 2025 | 0.0224 |
| June 30, 2025 | 0.0251 |
| March 31, 2025 | 0.0275 |
| December 31, 2024 | 0.0296 |
| September 30, 2024 | 0.029 |
| June 30, 2024 | 0.0319 |
| March 31, 2024 | 0.034 |
| December 31, 2023 | 0.0351 |
| September 30, 2023 | 0.0366 |
| June 30, 2023 | 0.0396 |
| March 31, 2023 | 0.0405 |
| December 31, 2022 | 0.0418 |
| September 30, 2022 | 0.0436 |
| June 30, 2022 | 0.0451 |
| March 31, 2022 | 0.0474 |
| December 31, 2021 | 0.0493 |
| September 30, 2021 | 0.0526 |
| June 30, 2021 | 0.0567 |
| March 31, 2021 | 0.0602 |
| December 31, 2020 | 0.0638 |
| September 30, 2020 | 0.0668 |
| June 30, 2020 | 0.071 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0709 |
| December 31, 2019 | 0.0718 |
| September 30, 2019 | 0.0739 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| HLS Therapeutics, Inc. | 0.7586 |
| Bausch Health Cos., Inc. | -11.73 |
| Cipher Pharmaceuticals, Inc. | 0.0027 |
| Revive Therapeutics Ltd. | -0.0176 |
| Knight Therapeutics, Inc. | 0.0429 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 60.46M |
| Total Liabilities (Quarterly) | 14.62M |
| Shareholders Equity (Quarterly) | 45.84M |
| Current Ratio | 2.068 |
| Net Debt Paydown Yield | -0.26% |